These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 20736770

  • 1. The significance of tumor involved adenomyosis in otherwise low-stage endometrioid adenocarcinoma.
    Hanley KZ, Dustin SM, Stoler MH, Atkins KA.
    Int J Gynecol Pathol; 2010 Sep; 29(5):445-51. PubMed ID: 20736770
    [Abstract] [Full Text] [Related]

  • 2. Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma.
    Ismiil ND, Rasty G, Ghorab Z, Nofech-Mozes S, Bernardini M, Thomas G, Ackerman I, Covens A, Khalifa MA.
    Int J Gynecol Pathol; 2007 Jul; 26(3):278-83. PubMed ID: 17581412
    [Abstract] [Full Text] [Related]

  • 3. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.
    Ismiil N, Rasty G, Ghorab Z, Nofech-Mozes S, Bernardini M, Ackerman I, Thomas G, Covens A, Khalifa MA.
    Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance.
    Murray SK, Young RH, Scully RE.
    Int J Gynecol Pathol; 2003 Oct; 22(4):324-33. PubMed ID: 14501811
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A, Cosio S, Fanucchi A, Cristofani R, Genazzani AR.
    Anticancer Res; 2000 Oct; 20(3B):1977-84. PubMed ID: 10928137
    [Abstract] [Full Text] [Related]

  • 10. Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma.
    Schwab KV, O'Malley DM, Fowler JM, Copeland LJ, Cohn DE.
    Gynecol Oncol; 2009 Jan; 112(1):146-9. PubMed ID: 18937970
    [Abstract] [Full Text] [Related]

  • 11. The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis.
    Nascimento AF, Hirsch MS, Cviko A, Quade BJ, Nucci MR.
    Mod Pathol; 2003 Jan; 16(1):22-7. PubMed ID: 12527709
    [Abstract] [Full Text] [Related]

  • 12. Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma.
    Ali A, Black D, Soslow RA.
    Int J Gynecol Pathol; 2007 Apr; 26(2):115-23. PubMed ID: 17413976
    [Abstract] [Full Text] [Related]

  • 13. Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role.
    Espinosa I, José Carnicer M, Catasus L, Canet B, D'angelo E, Zannoni GF, Prat J.
    Am J Surg Pathol; 2010 Nov; 34(11):1708-14. PubMed ID: 20962622
    [Abstract] [Full Text] [Related]

  • 14. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, Soper JT, Clarke-Pearson DL.
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [Abstract] [Full Text] [Related]

  • 15. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.
    Cirisano FD, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, Soper JT, Clarke-Pearson DL.
    Gynecol Oncol; 1999 Sep; 74(3):385-94. PubMed ID: 10479498
    [Abstract] [Full Text] [Related]

  • 16. Significance of lower uterine segment involvement in women with stage I endometrial adenocarcinoma.
    Gemer O, Uriev L, Harkovsky T, Peled R, Ben-Dor D, Barak F, Segal S.
    J Reprod Med; 2004 Sep; 49(9):703-6. PubMed ID: 15493559
    [Abstract] [Full Text] [Related]

  • 17. Prognostic significance of hysteroscopic imaging in endometrioid endometrial adenocarcinoma.
    Garuti G, De Giorgi O, Sambruni I, Cellani F, Luerti M.
    Gynecol Oncol; 2001 Jun; 81(3):408-13. PubMed ID: 11371130
    [Abstract] [Full Text] [Related]

  • 18. Diffusely infiltrative endometrial adenocarcinoma: an adenoma malignum pattern of myoinvasion.
    Longacre TA, Hendrickson MR.
    Am J Surg Pathol; 1999 Jan; 23(1):69-78. PubMed ID: 9888705
    [Abstract] [Full Text] [Related]

  • 19. Influences of uterine adenomyosis on muscle invasion and prognosis of endometrioid adenocarcinoma.
    Taneichi A, Fujiwara H, Takahashi Y, Takei Y, Machida S, Saga Y, Takahashi S, Suzuki M.
    Int J Gynecol Cancer; 2014 Oct; 24(8):1429-33. PubMed ID: 25188882
    [Abstract] [Full Text] [Related]

  • 20. Primary endometrioid adenocarcinoma of the vagina: a clinicopathologic study of 18 cases.
    Staats PN, Clement PB, Young RH.
    Am J Surg Pathol; 2007 Oct; 31(10):1490-501. PubMed ID: 17895749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.